Streetbeat News

Partnerships

GSK

ITOS

iTeos Therapeutics announced promising interim data from the GALAXIES Lung-201 Phase 2 study, sponsored by GSK, for the belrestotug and dostarlimab combination in treating high PD-L1 non-small cell lung cancer. The combination showed a high objective response rate and a favorable safety profile.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 8:47 am

SOPH

SOPHiA GENETICS, in collaboration with AstraZeneca, is presenting AI-driven research at ESMO 2024. The study focuses on using machine learning to identify NSCLC patients who would benefit most from combination immunotherapy.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 8:13 am

PUBM

PubMatic has partnered with Haleon to optimize video and CTV ads globally, enhancing supply path transparency and sustainability. This collaboration aims to improve efficiency and performance for Haleon's brands like Advil, Centrum, and Tums.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 8:02 am

MASI

QCOM

Masimo and Qualcomm have partnered to launch a next-generation smartwatch platform for OEMs, enhancing Wear OS capabilities. This collaboration aims to integrate Masimo's health monitoring technology with Qualcomm's Snapdragon Wear platform.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:50 am

GOOG

MASI

Masimo has partnered with Google to develop a comprehensive smartwatch reference platform for OEMs using Wear OS. This platform will integrate Masimo's biosensing capabilities with Google's software expertise.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:49 am

ACDVF

Air Canada and the pilots' union ALPA have reached a tentative four-year contract agreement, pending ratification. This agreement acknowledges the pilots' contributions and sets a framework for Air Canada's future growth.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:37 am

TRMB

Trimble has sold its global telematics business to Platform Science and will become a key investor with a 32.5% stake in the expanded business. This move is expected to positively impact Trimble's financial metrics.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:23 am

MXCT

MaxCyte, Inc. has entered a strategic platform license agreement with Kamau Therapeutics, allowing Kamau to use MaxCyte's Flow Electroporation® technology and ExPERT™ platform for gene correction therapies. MaxCyte will receive licensing fees and program-related revenue.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:08 am

BR

Broadridge's Wealth Lending Network has integrated with Morningstar Advisor Workstation to enhance lending services for advisors. This collaboration allows independent advisors to offer comprehensive advisory services with integrated securities-based lending (SBL) capabilities.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 5:40 am

APP

ARM

AVGO

BNTX

CHWY

KGC

MSTR

SMMT

VRT

WBD

Several large-cap stocks saw significant gains last week, with Summit Therapeutics, BioNTech, and Applovin among the top performers. Key drivers included strategic announcements, analyst upgrades, and market developments.

Portfolio Pulse from Lekha Gupta

September 15, 2024 | 3:49 pm